4
Changes in Ownership
Tarsus Pharmaceuticals, Inc. Filed Acc 0001661539-22-000005
Options or other derivatives
- CHIEF MEDICAL OFFICER acquired 146,621 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Trevejo Jose M. · CHIEF MEDICAL OFFICER
Table II: Derivative
2 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2022-02-01 | Grant or award : show line 1 in the form Employee Stock Option (right to buy) | +116,424 | $20.64 | 2032-01-31 | 116,424 | 116,424 | D |
| 2022-02-01 | Grant or award : show line 2 in the form Restricted Stock Units | +30,197 | 30,197 | 30,197 | D |
Loading xslF345X03/wf-form4_164392778280060.xml…